FN1, involved in cell adhesion and migration processes, has been reported to be crucial in tumor progression and as a potential biomarker in multiple cancers including colorectal cancer (29), gastric cancer (30, 31), ovarian cancer (32), and prostate cancer (33). This evidence concerns the gene FN1 and prostate carcinoma.